Pancreatic Cancer Research

ResearcherAsan Medical CenterNo recent work listed

Sarang Hong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8324-063X; OpenAlex author ID A5102873636. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2019: 1 paper · 2020: 3 papers · 2021: 3 papers · 2022: 2 papers · 2023: 1 paper

Papers 10

  1. Outcomes of Distal Pancreatectomy With Celiac Axis Resection for Pancreatic Cancer. First author DOI 10.1097/mpa.0000000000002218↗
  2. Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma. Co-author DOI 10.1177/17588359221097190↗
  3. Predictive Performance of Current Nodal Staging Systems in Various Categories of Pancreatic Cancer. Co-author DOI 10.1245/s10434-021-10641-7↗
  4. Analysis of KRAS Mutation Subtype in Tissue DNA and Cell-Free DNA Using Droplet Digital PCR and the Function of Cell-Free DNA as a Recurrence Predictive Marker… Co-author DOI 10.3390/biomedicines9111599↗
  5. Usefulness of Inflammation-Based Prognostic Scores in Patients with Surgically Treated Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/jcm10245784↗
  6. Preoperative serum carbohydrate antigen 19-9 levels predict early recurrence after the resection of early-stage pancreatic ductal adenocarcinoma. Co-author DOI 10.4240/wjgs.v13.i11.1423↗
  7. Arterial resection during pancreatectomy for pancreatic ductal adenocarcinoma with arterial invasion: A single-center experience with 109 patients. Co-author DOI 10.1097/md.0000000000022115↗
  8. Comparison of Minimally Invasive Versus Open Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Propensity Score Matching Analysis. Co-author DOI 10.3390/cancers12040982↗
  9. Association between Metformin Use and Clinical Outcomes Following Pancreaticoduodenectomy in Patients with Type 2 Diabetes and Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/jcm9061953↗
  10. Prognostic value of adjacent organ resection in patients with left-sided pancreatic ductal adenocarcinoma following distal pancreatectomy. Co-author DOI 10.1002/jhbp.627↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ki Byung Song · 10 shared papers, 2019–2023 · strength 1.22
  2. Dae Wook Hwang · 10 shared papers, 2019–2023 · strength 1.22
  3. Song Cheol Kim · 10 shared papers, 2019–2023 · strength 1.22
  4. Woohyung Lee · 9 shared papers, 2020–2023 · strength 1.13
  5. Yejong Park · 8 shared papers, 2020–2023 · strength 1.01
  6. Bong Jun Kwak · 4 shared papers, 2021–2023 · strength 0.59
  7. Jaewoo Kwon · 5 shared papers, 2019–2021 · strength 0.50
  8. Dakyum Shin · 4 shared papers, 2020–2023 · strength 0.50
  9. Eunsung Jun · 3 shared papers, 2021–2022 · strength 0.39
  10. Daegwang Yoo · 3 shared papers, 2019–2020 · strength 0.28
  11. Kyu‐pyo Kim · 1 shared paper, 2022 · strength 0.12
  12. Do Hyun Park · 1 shared paper, 2022 · strength 0.12
  13. Jin‐hong Park · 1 shared paper, 2022 · strength 0.12
  14. Sora Kang · 1 shared paper, 2022 · strength 0.12
  15. Tae Jun Song · 1 shared paper, 2022 · strength 0.12
  16. So Heun Lee · 1 shared paper, 2022 · strength 0.12
  17. Dong Wan Seo · 1 shared paper, 2022 · strength 0.12
  18. Baek‐Yeol Ryoo · 1 shared paper, 2022 · strength 0.12
  19. Changhoon Yoo · 1 shared paper, 2022 · strength 0.12
  20. Sang Soo Lee · 1 shared paper, 2022 · strength 0.12
  21. Dongwook Oh · 1 shared paper, 2022 · strength 0.12
  22. Min Kyu Sung · 1 shared paper, 2021 · strength 0.11
  23. Naru Kim · 1 shared paper, 2021 · strength 0.11
  24. Sang Hyun Shin · 1 shared paper, 2020 · strength 0.09
  25. Seung Jae Lee · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.